Q&A with Steve Tolle, IBM Watson Health Imaging's vice president of global business development and strategy

by John R. Fischer, Senior Reporter | January 02, 2018
Health IT RSNA

HCB News: In terms of medical imaging, what should we expect from IBM in 2018?

In addition to the products we’re launching, we also going to be announcing additional partnerships. We are of the mindset that if something exists and the science is strong and it provides value to the provider, we don’t want to reinvent it. So, when we look at solving breast cancer screening, there are lots of things you can do in that package. We don’t have to build at all. If your company doesn’t have a good product like a 3-D ultrasound for breast, then great. We’ll go get that.

You’ll see us make announcements about how we’re assembling components as part of our solutions and a lot of that will be through third parties. I think that’s a little bit of a different strategy. A lot of these smaller companies are just doing their work. We’re doing our work but we’re also saying, ‘Wait, I want that over there and I want that over there.’ It’s a good way to bring more value to the customer.

Back to HCB News

You Must Be Logged In To Post A Comment